The Claim
In patients with atherosclerotic cardiovascular disease on statin therapy, the prescribed statin dose is not an independent predictor of major cardiovascular events after adjustment for percent LDL-C reduction and attained LDL-C level.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
For patients with atherosclerotic cardiovascular disease taking statins, the amount of statin prescribed does not determine the risk of major heart events; instead, how much the LDL cholesterol level drops and the final cholesterol level achieved are what matter.
See the scientific wording
In patients with atherosclerotic cardiovascular disease on statin therapy, the statin dose itself is not an independent predictor of major cardiovascular events when adjusted for percent LDL-C reduction and attained LDL-C level, suggesting that the biological response to the drug matters more than the prescribed dose.
Lowering LDL cholesterol in the blood causes fatty deposits in artery walls to become more stable and less likely to rupture, while also reducing inflammation in the blood vessel lining. This prevents clots from forming and blocking arteries, which stops heart attacks and strokes.
What the research says
1 studyFor people with heart disease on statins, how much their cholesterol drops matters more than how strong the pill dose is — two people can take the same dose, but if one’s cholesterol drops more, they’re less likely to have a heart attack or stroke.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.